Cerity Partners LLC Sells 920 Shares of Revvity, Inc. (NYSE:RVTY)

Cerity Partners LLC decreased its position in Revvity, Inc. (NYSE:RVTY) by 5.4% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 16,210 shares of the company’s stock after selling 920 shares during the quarter. Cerity Partners LLC’s holdings in Revvity were worth $1,958,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also bought and sold shares of the company. Vanguard Group Inc. grew its holdings in Revvity by 1.1% during the fourth quarter. Vanguard Group Inc. now owns 14,290,211 shares of the company’s stock valued at $1,594,930,000 after purchasing an additional 156,679 shares during the period. Mitsubishi UFJ Asset Management Co. Ltd. grew its stake in shares of Revvity by 2.1% during the 4th quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 3,382,338 shares of the company’s stock valued at $384,234,000 after acquiring an additional 69,034 shares during the period. Geode Capital Management LLC increased its holdings in Revvity by 1.3% in the 4th quarter. Geode Capital Management LLC now owns 2,901,459 shares of the company’s stock worth $322,958,000 after acquiring an additional 37,666 shares in the last quarter. Norges Bank bought a new stake in Revvity during the 4th quarter worth approximately $127,801,000. Finally, Primecap Management Co. CA lifted its holdings in Revvity by 2.0% during the fourth quarter. Primecap Management Co. CA now owns 951,885 shares of the company’s stock valued at $106,240,000 after purchasing an additional 18,580 shares in the last quarter. 86.65% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

RVTY has been the subject of several research analyst reports. Raymond James reiterated an “outperform” rating and set a $145.00 target price (up previously from $140.00) on shares of Revvity in a research report on Monday, February 3rd. Barclays cut their price objective on shares of Revvity from $140.00 to $110.00 and set an “overweight” rating for the company in a report on Thursday, April 10th. Sanford C. Bernstein downgraded shares of Revvity from an “outperform” rating to a “market perform” rating and set a $130.00 target price on the stock. in a report on Friday, January 10th. Finally, KeyCorp raised their target price on shares of Revvity from $132.00 to $145.00 and gave the company an “overweight” rating in a research note on Monday, February 3rd. Four analysts have rated the stock with a hold rating, eight have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $133.75.

Insider Buying and Selling at Revvity

In related news, insider Joel S. Goldberg sold 15,170 shares of the firm’s stock in a transaction that occurred on Thursday, January 30th. The shares were sold at an average price of $126.73, for a total transaction of $1,922,494.10. Following the sale, the insider now owns 33,400 shares in the company, valued at approximately $4,232,782. This trade represents a 31.23 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.68% of the stock is owned by corporate insiders.

Revvity Trading Down 1.8 %

NYSE:RVTY opened at $93.79 on Thursday. Revvity, Inc. has a 1 year low of $89.61 and a 1 year high of $129.50. The stock has a market cap of $11.27 billion, a P/E ratio of 42.44, a P/E/G ratio of 3.82 and a beta of 1.07. The company has a debt-to-equity ratio of 0.41, a quick ratio of 3.03 and a current ratio of 3.60. The stock has a 50-day simple moving average of $107.64 and a 200-day simple moving average of $114.62.

Revvity (NYSE:RVTY) last announced its quarterly earnings results on Friday, January 31st. The company reported $1.42 earnings per share for the quarter, beating analysts’ consensus estimates of $1.37 by $0.05. Revvity had a net margin of 9.81% and a return on equity of 7.68%. During the same period in the previous year, the firm earned $1.25 earnings per share. As a group, analysts anticipate that Revvity, Inc. will post 4.94 earnings per share for the current fiscal year.

Revvity Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, May 9th. Shareholders of record on Friday, April 18th will be given a dividend of $0.07 per share. The ex-dividend date is Thursday, April 17th. This represents a $0.28 dividend on an annualized basis and a yield of 0.30%. Revvity’s payout ratio is 12.67%.

Revvity Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.